Narrows Institute Of Biomedical Research Inc
Narrows Institute Of Biomedical Research Inc maintains stable finances with no reported officer compensation.
EIN: 113059470 · Brooklyn, NY · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $4.0M |
| Total Expenses | $3.7M |
| Program Spending | 85% |
| CEO/Top Officer Pay | $4 |
| Net Assets | $984K |
| Transparency Score | 85/100 |
Is Narrows Institute Of Biomedical Research Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Narrows Institute Of Biomedical Research Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Narrows Institute Of Biomedical Research Inc
Narrows Institute Of Biomedical Research Inc (EIN: 113059470) is a nonprofit organization based in Brooklyn, NY. The organization reported total revenue of $4.0M and total assets of $1.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Narrows Institute Of Biomedical Research Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Narrows Institute Of Biomedical Research Inc is a mid-size nonprofit that has been operating for 35 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 8.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.8M |
| Total Expenses | $3.7M |
| Surplus / Deficit | +$75K |
| Total Assets | $2.3M |
| Total Liabilities | $1.3M |
| Net Assets | $984K |
| Operating Margin | 2.0% |
| Debt-to-Asset Ratio | 56.9% |
| Months of Reserves | 7.4 months |
Financial Health Grade: A
In 2023, Narrows Institute Of Biomedical Research Inc reported a surplus of $75K with revenue exceeding expenses, holds 7.4 months of operating reserves (strong position), has a debt-to-asset ratio of 56.9% (high leverage).
Financial Trends
Over 13 years of filings (2011–2023), Narrows Institute Of Biomedical Research Inc's revenue has grown at a compound annual growth rate (CAGR) of 8.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +32.1% | +16.5% | -4.0% |
| 2022 | -22.5% | -7.6% | +5.5% |
| 2021 | +35.4% | +7.5% | -5.3% |
| 2020 | -20.7% | +8.7% | +2.6% |
| 2019 | +66.8% | +55.7% | +48.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1991 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Narrows Institute Of Biomedical Research Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Narrows Institute Of Biomedical Research Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $75K, with revenue exceeding expenses.
- Debt-to-asset ratio: 56.9%.
Executive Compensation Analysis
Executive compensation is consistently reported as 0% across all available filings, indicating that no salaries are paid to officers, which is highly unusual for an organization of this size with revenues approaching $4 million.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Narrows Institute Of Biomedical Research Inc's IRS 990 filings:
- NTEE Code Unknown: Lack of a specified NTEE code makes it difficult to benchmark against similar organizations and understand its specific programmatic focus.
- Unusually Low Officer Compensation: Consistent 0% officer compensation for an organization with nearly $4 million in revenue is highly unusual and warrants further investigation into how leadership is compensated or structured.
Strengths
The following positive indicators were identified for Narrows Institute Of Biomedical Research Inc:
- Strong Program Focus: Consistent 0% officer compensation across all filings suggests a high dedication of resources to the organization's mission.
- Consistent Revenue Growth: Revenue has grown significantly from $894,296 in 201609 to $3,794,366 in 202309, indicating successful fundraising and operational expansion.
- Healthy Asset-to-Liability Ratio: With assets of $2,281,786 and liabilities of $1,297,965 in 202309, the organization maintains a solid financial foundation.
- Financial Stability: Expenses are generally well-managed relative to revenue, with a slight surplus in the latest filing ($3,794,366 revenue vs. $3,719,202 expenses in 202309).
Frequently Asked Questions about Narrows Institute Of Biomedical Research Inc
Is Narrows Institute Of Biomedical Research Inc a legitimate charity?
Narrows Institute Of Biomedical Research Inc (EIN: 113059470) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $4.0M. 2 red flags identified. 4 strengths noted. Financial health grade: A.
How does Narrows Institute Of Biomedical Research Inc spend its money?
Narrows Institute Of Biomedical Research Inc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Narrows Institute Of Biomedical Research Inc tax-deductible?
Narrows Institute Of Biomedical Research Inc is registered as a tax-exempt nonprofit (EIN: 113059470). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Narrows Institute Of Biomedical Research Inc CEO make?
Narrows Institute Of Biomedical Research Inc's highest-compensated officer earns $4 annually. The organization reported $4.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Narrows Institute Of Biomedical Research Inc's spending goes to programs?
Narrows Institute Of Biomedical Research Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is Narrows Institute Of Biomedical Research Inc located?
Narrows Institute Of Biomedical Research Inc is headquartered in Brooklyn, New York and files with the IRS under EIN 113059470.
How many years of IRS 990 filings does Narrows Institute Of Biomedical Research Inc have?
Narrows Institute Of Biomedical Research Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $4.0M in total revenue.
Is Narrows Institute Of Biomedical Research Inc a good charity?
Based on the available financial data, the organization appears to be financially stable, with consistent revenue and expenses, and notably, reports 0% officer compensation, suggesting a strong commitment to directing funds towards its mission. However, a full assessment would benefit from knowing their NTEE code and detailed program spending.
How has Narrows Institute Of Biomedical Research Inc's revenue grown over time?
The organization has shown significant revenue growth, increasing from $894,296 in 201609 to $3,794,366 in 202309, demonstrating a substantial expansion in its financial capacity.
What is the organization's asset-to-liability ratio?
In the latest filing (202309), Narrows Institute Of Biomedical Research Inc had assets of $2,281,786 and liabilities of $1,297,965, resulting in an asset-to-liability ratio of approximately 1.76:1, indicating a healthy financial position.
Filing History
IRS 990 filing history for Narrows Institute Of Biomedical Research Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Narrows Institute Of Biomedical Research Inc's revenue has grown by 177.3%, moving from $1.4M to $3.8M. Total assets increased by 51.6% over the same period, from $1.5M to $2.3M. Total functional expenses rose by 168.3%, from $1.4M to $3.7M. In its most recent filing year (2023), Narrows Institute Of Biomedical Research Inc reported a surplus of $75K, with revenue exceeding expenses. The organization holds $1.3M in liabilities against $2.3M in assets (debt-to-asset ratio: 56.9%), resulting in net assets of $984K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $3.8M | $3.7M | $2.3M | $1.3M | — | View 990 |
| 2022 | $2.9M | $3.2M | $2.4M | $1.5M | — | View 990 |
| 2021 | $3.7M | $3.5M | $2.3M | $1.0M | — | View 990 |
| 2020 | $2.7M | $3.2M | $2.4M | $1.4M | — | View 990 |
| 2019 | $3.5M | $3.0M | $2.3M | $870K | — | View 990 |
| 2018 | $2.1M | $1.9M | $1.6M | $610K | — | View 990 |
| 2017 | $1.0M | $1.2M | $890K | $114K | — | View 990 |
| 2016 | $894K | $1.1M | $1.0M | $122K | — | View 990 |
| 2015 | $1.2M | $1.4M | $1.3M | $100K | — | View 990 |
| 2014 | $1.7M | $1.2M | $1.4M | $88K | — | View 990 |
| 2013 | $909K | $1.2M | $1.1M | $286K | — | View 990 |
| 2012 | $1.0M | $1.2M | $1.4M | $311K | — | View 990 |
| 2011 | $1.4M | $1.4M | $1.5M | $316K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $3.8M, expenses of $3.7M, and assets of $2.3M (revenue +32.1% year-over-year).
- 2022: Revenue of $2.9M, expenses of $3.2M, and assets of $2.4M (revenue -22.5% year-over-year).
- 2021: Revenue of $3.7M, expenses of $3.5M, and assets of $2.3M (revenue +35.4% year-over-year).
- 2020: Revenue of $2.7M, expenses of $3.2M, and assets of $2.4M (revenue -20.7% year-over-year).
- 2019: Revenue of $3.5M, expenses of $3.0M, and assets of $2.3M (revenue +66.8% year-over-year).
- 2018: Revenue of $2.1M, expenses of $1.9M, and assets of $1.6M (revenue +100.9% year-over-year).
- 2017: Revenue of $1.0M, expenses of $1.2M, and assets of $890K (revenue +15.3% year-over-year).
- 2016: Revenue of $894K, expenses of $1.1M, and assets of $1.0M (revenue -25.6% year-over-year).
- 2015: Revenue of $1.2M, expenses of $1.4M, and assets of $1.3M (revenue -28.6% year-over-year).
- 2014: Revenue of $1.7M, expenses of $1.2M, and assets of $1.4M (revenue +85.2% year-over-year).
- 2013: Revenue of $909K, expenses of $1.2M, and assets of $1.1M (revenue -12.4% year-over-year).
- 2012: Revenue of $1.0M, expenses of $1.2M, and assets of $1.4M (revenue -24.1% year-over-year).
- 2011: Revenue of $1.4M, expenses of $1.4M, and assets of $1.5M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Narrows Institute Of Biomedical Research Inc:
Data Sources and Methodology
This transparency report for Narrows Institute Of Biomedical Research Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.